FR2953137B1 - Utilisation d'un compose dipyridyl pour traiter la rosacee - Google Patents

Utilisation d'un compose dipyridyl pour traiter la rosacee

Info

Publication number
FR2953137B1
FR2953137B1 FR0958478A FR0958478A FR2953137B1 FR 2953137 B1 FR2953137 B1 FR 2953137B1 FR 0958478 A FR0958478 A FR 0958478A FR 0958478 A FR0958478 A FR 0958478A FR 2953137 B1 FR2953137 B1 FR 2953137B1
Authority
FR
France
Prior art keywords
treating rosacea
dipyridyl compound
dipyridyl
compound
rosacea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0958478A
Other languages
English (en)
Other versions
FR2953137A1 (fr
Inventor
Irina Safonova
Jean Dominique Pierret
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to FR0958478A priority Critical patent/FR2953137B1/fr
Priority to PCT/FR2010/052543 priority patent/WO2011064508A1/fr
Priority to EP10799113A priority patent/EP2506851A1/fr
Priority to CA2782048A priority patent/CA2782048A1/fr
Priority to US13/512,832 priority patent/US20120322829A1/en
Publication of FR2953137A1 publication Critical patent/FR2953137A1/fr
Application granted granted Critical
Publication of FR2953137B1 publication Critical patent/FR2953137B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0958478A 2009-11-30 2009-11-30 Utilisation d'un compose dipyridyl pour traiter la rosacee Expired - Fee Related FR2953137B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0958478A FR2953137B1 (fr) 2009-11-30 2009-11-30 Utilisation d'un compose dipyridyl pour traiter la rosacee
PCT/FR2010/052543 WO2011064508A1 (fr) 2009-11-30 2010-11-26 Utilisation d'un composé dipyridyl pour traiter la rosacée
EP10799113A EP2506851A1 (fr) 2009-11-30 2010-11-26 Utilisation d'un composé dipyridyl pour traiter la rosacée
CA2782048A CA2782048A1 (fr) 2009-11-30 2010-11-26 Utilisation d'un compose dipyridyl pour traiter la rosacee
US13/512,832 US20120322829A1 (en) 2009-11-30 2010-11-26 Use of a dipyridyl compound for treating rosacea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0958478A FR2953137B1 (fr) 2009-11-30 2009-11-30 Utilisation d'un compose dipyridyl pour traiter la rosacee

Publications (2)

Publication Number Publication Date
FR2953137A1 FR2953137A1 (fr) 2011-06-03
FR2953137B1 true FR2953137B1 (fr) 2012-01-13

Family

ID=42244146

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0958478A Expired - Fee Related FR2953137B1 (fr) 2009-11-30 2009-11-30 Utilisation d'un compose dipyridyl pour traiter la rosacee

Country Status (5)

Country Link
US (1) US20120322829A1 (fr)
EP (1) EP2506851A1 (fr)
CA (1) CA2782048A1 (fr)
FR (1) FR2953137B1 (fr)
WO (1) WO2011064508A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9801848B2 (en) * 2013-03-13 2017-10-31 The Regents Of The University Of California Prevention of rosacea inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE176396T1 (de) * 1987-10-22 1999-02-15 Procter & Gamble Chelatbildner enthaltende lichtschutzmittel
US20060074108A1 (en) * 2004-10-04 2006-04-06 Bioderm Research Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition
ZA200706806B (en) * 2005-01-20 2008-10-29 Hatchtech Pty Ltd Methods and compositions for controlling ectoparasites

Also Published As

Publication number Publication date
US20120322829A1 (en) 2012-12-20
EP2506851A1 (fr) 2012-10-10
WO2011064508A1 (fr) 2011-06-03
FR2953137A1 (fr) 2011-06-03
CA2782048A1 (fr) 2011-06-03

Similar Documents

Publication Publication Date Title
NL301166I2 (nl) Avacopan of een farmaceutisch aanvaardbaar zout daarvan
NL301071I2 (nl) alpelisib of een farmaceutisch aanvaardbaar zout ervan
NL301096I2 (nl) Filgotinib of een zout daarvan
NL301028I2 (nl) Gilteritinib of een zout ervan
SMT201600320B (it) Composizione a deposito iniettabile antipsicotica
SMT201500291B (it) Nuovi agenti antimalarici
FR2924330B1 (fr) Implant pour hernie parastomiale
BRPI1005527A8 (pt) gerenciamento de direitos de conversação
BRPI1010134A2 (pt) guindaste rolante
FR2966403B1 (fr) Barre de feux d'urgence mince
BRPI0816310A2 (pt) Nova fórmula de niacina de liberação controlada
FI20105052A0 (fi) Siltanosturi
IT1404614B1 (it) Rivestimento multistrato anti-impatto
BR112013007040A2 (pt) "método para preparar um composto e composto"
DK2455322T3 (da) Kran
FI20105941A0 (fi) Kipsausmateriaalit
BR112013014966A2 (pt) composto aricíclico contínuo
PL2431525T3 (pl) Żelbetowy dźwigar zespolony dla konstrukcji mostu
FR2961810B1 (fr) Esters de metronidazole pour traiter la rosacee
FR2967446B1 (fr) Portillon pour porte sectionnelle
FR2953137B1 (fr) Utilisation d'un compose dipyridyl pour traiter la rosacee
FR2948387B3 (fr) Regard pour conduites
FR2919487B1 (fr) Devidoir pour bandelette chirurgicale
FR2959773B1 (fr) Sas pour personnes
FI20105376A (fi) Väline köysisidoksen tekemiseksi

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140731